Watch on Radcliffe Vascular:
In this short interview, Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, DE) joins us on-site at LINC 2022 to outline the findings of a study evaluating the safety and efficacy of Cagent Vascular's Serranator® PTA balloon catheter in patients with peripheral artery disease.
Discussion Points:
1. Serranator® PTA Study Device
2. Reasoning For This Study
3. Inclusion/Exclusion Criteria and Study Design
4. Outcomes
5. Conclusions
6. Further Study Needed
Recorded onsite at LINC 2022, Leipzig.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.